Pulse Biosciences CS (PLSE)

$46.00 -0.79 (-1.69%)
Market Cap 3.24B
Revenue (ttm) 350,000.00
Net Income (ttm) -72.78M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -20,794.29%
Debt to Equity Ratio 0.00
Volume 526,000
Avg Vol 390,354
Day's Range N/A - N/A
Shares Out 69.21M
Stochastic %K 80%
Beta 1.61
Analysts Strong Sell
Price Target $45.25

Company Profile

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment c...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 510 906 4600
Address:
601 Brickell Key Drive, Suite 1080, Miami, United States
LeisureSuitLarry
LeisureSuitLarry Aug. 18 at 1:37 PM
$PLSE 💪🏻
0 · Reply
TruthBroker2
TruthBroker2 Aug. 17 at 8:31 PM
$PLSE
0 · Reply
MaverikIT
MaverikIT Aug. 17 at 7:53 PM
@cynicaloptimist @Jblack500 @WAJeff let's $TWST and $PLSE ing again $NTRA $TXG ...
1 · Reply
TruthBroker2
TruthBroker2 Aug. 17 at 5:13 PM
$PLSE #1
0 · Reply
LeisureSuitLarry
LeisureSuitLarry Aug. 17 at 2:34 PM
$PLSE
0 · Reply
bob2013
bob2013 Aug. 17 at 11:58 AM
$PLSE Farapulse, please make room!! ( HE KNOWS)!!!
0 · Reply
nhjxie
nhjxie Aug. 17 at 9:32 AM
$PLSE elephants just started to jump into this small pond…
1 · Reply
TruthBroker2
TruthBroker2 Aug. 14 at 7:20 PM
$PLSE Long N Strong $SMMT
0 · Reply
ActionMack
ActionMack Aug. 14 at 4:59 PM
$PLSE dump and run
1 · Reply
letstalk8
letstalk8 Aug. 14 at 4:01 PM
$PLSE Time to cover your short and move on
2 · Reply
Latest News on PLSE
Pulse Biosciences announces inducement grants under Nasdaq listing rule

2026-08-18T11:10:42.000Z - 1 day ago

Pulse Biosciences announces inducement grants under Nasdaq listing rule

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aug 18, 2026, 7:00 AM EDT - 1 day ago

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Pulse Biosciences initiated with a Buy at Needham

2026-08-17T10:45:50.000Z - 2 days ago

Pulse Biosciences initiated with a Buy at Needham

Pulse Biosciences management to meet virtually with BTIG

2026-08-16T13:55:58.000Z - 2 days ago

Pulse Biosciences management to meet virtually with BTIG

Pulse Biosciences Transcript: Canaccord Genuity's 46th Annual Growth Conference

Aug 11, 2026, 2:30 PM EDT - 7 days ago

Pulse Biosciences Transcript: Canaccord Genuity's 46th Annual Growth Conference

Pulse Biosciences management to meet virtually with BTIG

2026-08-10T18:45:07.000Z - 8 days ago

Pulse Biosciences management to meet virtually with BTIG

Pulse Biosciences price target raised to $43 from $32 at Canaccord

2026-08-10T11:20:41.000Z - 9 days ago

Pulse Biosciences price target raised to $43 from $32 at Canaccord

Pulse Biosciences price target raised to $45 from $30 at Mizuho

2026-08-10T11:20:36.000Z - 9 days ago

Pulse Biosciences price target raised to $45 from $30 at Mizuho

Pulse Biosciences Slides: Investor presentation

Aug 7, 2026, 8:00 AM EDT - 12 days ago

Pulse Biosciences Slides: Investor presentation

Pulse Biosciences reports Q2 EPS (36c) vs (28c) last year

2026-08-06T21:07:02.000Z - 12 days ago

Pulse Biosciences reports Q2 EPS (36c) vs (28c) last year

Pulse Biosciences Earnings Call Transcript: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 12 days ago

Pulse Biosciences Earnings Call Transcript: Q2 2026

Pulse Biosciences Earnings release: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 12 days ago

Pulse Biosciences Earnings release: Q2 2026

Pulse Biosciences Quarterly report: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 12 days ago

Pulse Biosciences Quarterly report: Q2 2026

Pulse Biosciences Reports Business Updates and Second Quarter 2026 Financial Results

Aug 6, 2026, 4:05 PM EDT - 12 days ago

Pulse Biosciences Reports Business Updates and Second Quarter 2026 Financial Results

Pulse Biosciences management to meet with BTIG

2026-08-04T16:25:52.000Z - 14 days ago

Pulse Biosciences management to meet with BTIG

Pulse Biosciences to Present at Canaccord Genuity's 46th Annual Growth Conference

Jul 30, 2026, 4:05 PM EDT - 19 days ago

Pulse Biosciences to Present at Canaccord Genuity's 46th Annual Growth Conference

Pulse Biosciences surpasses enrollment midpoint in NANOPULSE-AF study

2026-07-29T11:20:37.000Z - 21 days ago

Pulse Biosciences surpasses enrollment midpoint in NANOPULSE-AF study

Pulse Biosciences Surpasses Enrollment Midpoint in NANOPULSE-AF IDE Pivotal Study

Jul 29, 2026, 7:00 AM EDT - 21 days ago

Pulse Biosciences Surpasses Enrollment Midpoint in NANOPULSE-AF IDE Pivotal Study

Pulse Biosciences price target raised to $35 from $30 at Oppenheimer

2026-07-28T11:35:24.000Z - 22 days ago

Pulse Biosciences price target raised to $35 from $30 at Oppenheimer

Pulse Biosciences Schedules Second Quarter 2026 Financial Results Conference Call for August 6, 2026

Jul 21, 2026, 4:05 PM EDT - 4 weeks ago

Pulse Biosciences Schedules Second Quarter 2026 Financial Results Conference Call for August 6, 2026

Pulse Biosciences Transcript: AGM 2026

Jun 11, 2026, 11:00 AM EDT - 2 months ago

Pulse Biosciences Transcript: AGM 2026

Pulse Biosciences Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 10, 2026, 10:00 AM EDT - 2 months ago

Pulse Biosciences Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Pulse Biosciences announces planned redemption of warrants

2026-06-10T11:11:17.000Z - 2 months ago

Pulse Biosciences announces planned redemption of warrants

Pulse Biosciences, Inc. Announces Planned Redemption of Warrants

Jun 10, 2026, 7:00 AM EDT - 2 months ago

Pulse Biosciences, Inc. Announces Planned Redemption of Warrants

Canaccord starts Pulse Biosciences with Buy on ablation potential

2026-06-04T10:46:18.000Z - 2 months ago

Canaccord starts Pulse Biosciences with Buy on ablation potential

Pulse Biosciences initiated with a Buy at Canaccord

2026-06-04T10:26:01.000Z - 2 months ago

Pulse Biosciences initiated with a Buy at Canaccord

Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026

May 27, 2026, 4:05 PM EDT - 2 months ago

Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026

Pulse Biosciences Transcript: Bank of America Global Healthcare Conference 2026

May 13, 2026, 7:35 PM EDT - 3 months ago

Pulse Biosciences Transcript: Bank of America Global Healthcare Conference 2026

Pulse Biosciences Slides: Corporate presentation

May 13, 2026, 7:00 AM EDT - 3 months ago

Pulse Biosciences Slides: Corporate presentation

Pulse Biosciences announces ATM equity purchases by co-chairmen

2026-05-12T12:29:42.000Z - 3 months ago

Pulse Biosciences announces ATM equity purchases by co-chairmen

ATM Equity Purchases by Pulse Biosciences' Co-Chairmen Total Approximately $13.3 Million

May 12, 2026, 7:00 AM EDT - 3 months ago

ATM Equity Purchases by Pulse Biosciences' Co-Chairmen Total Approximately $13.3 Million

Pulse Biosciences Proxy statement: Proxy filing

May 11, 2026, 8:00 AM EDT - 3 months ago

Pulse Biosciences Proxy statement: Proxy filing

Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference

May 8, 2026, 7:00 AM EDT - 3 months ago

Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference

Pulse Biosciences Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Pulse Biosciences Earnings Call Transcript: Q1 2026

Pulse Biosciences Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Pulse Biosciences Earnings release: Q1 2026

Pulse Biosciences Quarterly report: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Pulse Biosciences Quarterly report: Q1 2026

Pulse Biosciences reports Q1 EPS (27c) vs (25c) last year

2026-05-04T11:10:11.000Z - 3 months ago

Pulse Biosciences reports Q1 EPS (27c) vs (25c) last year

Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Results

May 4, 2026, 7:00 AM EDT - 3 months ago

Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Results

Pulse Biosciences presents clinical data from nPulse Cardiac Catheter System

2026-04-26T17:40:28.000Z - 4 months ago

Pulse Biosciences presents clinical data from nPulse Cardiac Catheter System

Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse™ Cardiac Catheter System at Heart Rhythm 2026

Apr 25, 2026, 1:00 PM EDT - 4 months ago

Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse™ Cardiac Catheter System at Heart Rhythm 2026

Pulse Biosciences to feature nPulse tech at Heart Rhythm Society meeting

2026-04-20T12:09:41.000Z - 4 months ago

Pulse Biosciences to feature nPulse tech at Heart Rhythm Society meeting

Pulse Biosciences' nPulse™ Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting

Apr 20, 2026, 7:00 AM EDT - 4 months ago

Pulse Biosciences' nPulse™ Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting

Pulse Biosciences to Host Analyst Event on April 25, 2026

Apr 17, 2026, 7:00 AM EDT - 4 months ago

Pulse Biosciences to Host Analyst Event on April 25, 2026

Pulse Biosciences Transcript: 25th Annual Needham Virtual Healthcare Conference

Apr 16, 2026, 9:30 AM EDT - 4 months ago

Pulse Biosciences Transcript: 25th Annual Needham Virtual Healthcare Conference

Pulse Biosciences Slides: Corporate presentation

Apr 16, 2026, 7:00 AM EDT - 4 months ago

Pulse Biosciences Slides: Corporate presentation

Pulse Biosciences appoints Teplitsky as Chief Operating Officer

2026-04-09T11:44:40.000Z - 4 months ago

Pulse Biosciences appoints Teplitsky as Chief Operating Officer

Pulse Biosciences Strengthens Executive Leadership Team

Apr 9, 2026, 7:00 AM EDT - 4 months ago

Pulse Biosciences Strengthens Executive Leadership Team

Pulse Biosciences enrolls first patients in NANOPULSE-AF study

2026-04-07T11:27:19.000Z - 4 months ago

Pulse Biosciences enrolls first patients in NANOPULSE-AF study

Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation

Apr 7, 2026, 7:00 AM EDT - 4 months ago

Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation

Pulse Biosciences to Present at the 25th Annual Needham Virtual Healthcare Conference

Apr 2, 2026, 4:05 PM EDT - 4 months ago

Pulse Biosciences to Present at the 25th Annual Needham Virtual Healthcare Conference

Pulse Biosciences Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Mar 18, 2026, 10:40 AM EDT - 5 months ago

Pulse Biosciences Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Pulse to accelerate development of nPulse Cardiac Catheter Ablarton System

2026-03-17T11:21:11.000Z - 5 months ago

Pulse to accelerate development of nPulse Cardiac Catheter Ablarton System

Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data

Mar 17, 2026, 7:00 AM EDT - 5 months ago

Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data

Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse™ Technology

Mar 12, 2026, 7:00 AM EDT - 5 months ago

Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse™ Technology

Pulse Biosciences Announces Clinical Data From nPulse™ Vybrance™ System First-In-Human Clinical Durability Study of Benign Thyroid Nodule Ablation

Mar 9, 2026, 7:00 AM EDT - 5 months ago

Pulse Biosciences Announces Clinical Data From nPulse™ Vybrance™ System First-In-Human Clinical Durability Study of Benign Thyroid Nodule Ablation

Pulse Biosciences to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Mar 5, 2026, 7:00 AM EST - 5 months ago

Pulse Biosciences to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Pulse Biosciences Transcript: TD Cowen 46th Annual Health Care Conference

Mar 4, 2026, 1:10 PM EST - 5 months ago

Pulse Biosciences Transcript: TD Cowen 46th Annual Health Care Conference

Pulse Biosciences' nPulse™ Vybrance™ System to be Featured in Multiple Presentations at the North American Society for Interventional Thyroidology Meeting

Mar 4, 2026, 7:00 AM EST - 6 months ago

Pulse Biosciences' nPulse™ Vybrance™ System to be Featured in Multiple Presentations at the North American Society for Interventional Thyroidology Meeting

Pulse Biosciences Slides: Corporate presentation

Mar 3, 2026, 6:00 AM EST - 6 months ago

Pulse Biosciences Slides: Corporate presentation

Pulse Biosciences to Present at the 46th Annual TD Cowen Healthcare Conference

Feb 20, 2026, 7:00 AM EST - 6 months ago

Pulse Biosciences to Present at the 46th Annual TD Cowen Healthcare Conference

Pulse Biosciences Earnings Call Transcript: Q4 2025

Feb 19, 2026, 4:30 PM EST - 6 months ago

Pulse Biosciences Earnings Call Transcript: Q4 2025

Pulse Biosciences Earnings release: Q4 2025

Feb 19, 2026, 4:30 PM EST - 6 months ago

Pulse Biosciences Earnings release: Q4 2025

Pulse Biosciences Annual report: Q4 2025

Feb 19, 2026, 4:30 PM EST - 6 months ago

Pulse Biosciences Annual report: Q4 2025

Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2025 Financial Results

Feb 19, 2026, 4:05 PM EST - 6 months ago

Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2025 Financial Results

Pulse Biosciences Registration statement: Registration Filing

Feb 19, 2026, 7:00 AM EST - 6 months ago

Pulse Biosciences Registration statement: Registration Filing

Pulse Biosciences Press release: FY 2026

Feb 6, 2026, 7:00 AM EST - 6 months ago

Pulse Biosciences Press release: FY 2026

Pulse Biosciences Slides: FY 2026

Feb 6, 2026, 7:00 AM EST - 6 months ago

Pulse Biosciences Slides: FY 2026

Pulse Biosciences Presents Late-Breaking Data from nPulse™ Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium

Feb 5, 2026, 7:00 PM EST - 6 months ago

Pulse Biosciences Presents Late-Breaking Data from nPulse™ Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium

Pulse Biosciences Schedules Fourth Quarter & Full Year 2025 Financial Results Conference Call for February 19, 2026

Feb 4, 2026, 4:05 PM EST - 6 months ago

Pulse Biosciences Schedules Fourth Quarter & Full Year 2025 Financial Results Conference Call for February 19, 2026

Pulse Biosciences' nPulse™ Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium

Feb 3, 2026, 7:00 AM EST - 7 months ago

Pulse Biosciences' nPulse™ Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium

Pulse Biosciences Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 6:45 PM EST - 7 months ago

Pulse Biosciences Transcript: 44th Annual J.P. Morgan Healthcare Conference

Pulse Biosciences Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 6:45 PM EST - 7 months ago

Pulse Biosciences Slides: 44th Annual J.P. Morgan Healthcare Conference

Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors

Jan 9, 2026, 7:00 AM EST - 7 months ago

Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors

Pulse Biosciences Selected to Present Late-Breaking Data from the nPulse Cardiac Catheter Study at the AF Symposium

Jan 6, 2026, 7:00 AM EST - 8 months ago

Pulse Biosciences Selected to Present Late-Breaking Data from the nPulse Cardiac Catheter Study at the AF Symposium

Pulse Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 29, 2025, 4:05 PM EST - 8 months ago

Pulse Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation

Dec 18, 2025, 7:00 AM EST - 8 months ago

Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation

Pulse Biosciences, Inc. Announces Initiation of Research Collaboration for the Treatment of Benign and Malignant Thyroid Tumors with nPulse™ Technology

Dec 9, 2025, 7:00 AM EST - 9 months ago

Pulse Biosciences, Inc. Announces Initiation of Research Collaboration for the Treatment of Benign and Malignant Thyroid Tumors with nPulse™ Technology

Pulse Biosciences Transcript: Piper Sandler 37th Annual Healthcare Conference

Dec 3, 2025, 9:50 AM EST - 9 months ago

Pulse Biosciences Transcript: Piper Sandler 37th Annual Healthcare Conference

Pulse Biosciences Transcript: Stifel 2025 Healthcare Conference

Nov 13, 2025, 2:40 PM EST - 9 months ago

Pulse Biosciences Transcript: Stifel 2025 Healthcare Conference

Pulse Biosciences Slides: Corporate Presentation

Nov 11, 2025, 6:00 PM EST - 10 months ago

Pulse Biosciences Slides: Corporate Presentation

Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences

Nov 6, 2025, 4:05 PM EST - 10 months ago

Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences

Pulse Biosciences Earnings Call Transcript: Q3 2025

Nov 5, 2025, 4:30 PM EST - 10 months ago

Pulse Biosciences Earnings Call Transcript: Q3 2025

Pulse Biosciences Quarterly report: Q3 2025

Nov 5, 2025, 4:30 PM EST - 10 months ago

Pulse Biosciences Quarterly report: Q3 2025

Pulse Biosciences Earnings release: Q3 2025

Nov 5, 2025, 4:30 PM EST - 10 months ago

Pulse Biosciences Earnings release: Q3 2025

Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results

Nov 5, 2025, 4:05 PM EST - 10 months ago

Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results

Pulse Biosciences Proxy statement: Proxy Filing

Oct 28, 2025, 8:00 AM EDT - 10 months ago

Pulse Biosciences Proxy statement: Proxy Filing

Pulse Biosciences Proxy statement: Proxy Filing

Oct 28, 2025, 8:00 AM EDT - 10 months ago

Pulse Biosciences Proxy statement: Proxy Filing

Pulse Biosciences Announces First Enrollment in the NANOCLAMP AF Study

Oct 24, 2025, 7:00 AM EDT - 10 months ago

Pulse Biosciences Announces First Enrollment in the NANOCLAMP AF Study

Pulse Biosciences Schedules Third Quarter 2025 Business Updates and Financial Results Conference Call for November 5, 2025

Oct 22, 2025, 4:05 PM EDT - 10 months ago

Pulse Biosciences Schedules Third Quarter 2025 Business Updates and Financial Results Conference Call for November 5, 2025

Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse™ Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting

Oct 10, 2025, 7:00 AM EDT - 11 months ago

Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse™ Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting

Pulse Biosciences Announces Clinical Data Highlighting its nPulse™ Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting

Oct 7, 2025, 7:00 AM EDT - 11 months ago

Pulse Biosciences Announces Clinical Data Highlighting its nPulse™ Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting

Pulse Biosciences' nPulse™ Technology to be Featured at the American Thyroid Association 2025 Annual Meeting

Sep 10, 2025, 7:00 AM EDT - 1 year ago

Pulse Biosciences' nPulse™ Technology to be Featured at the American Thyroid Association 2025 Annual Meeting

Pulse Biosciences Announces FDA IDE Approval to Initiate its nsPFA Cardiac Surgery System Study for the Treatment of Atrial Fibrillation

Sep 8, 2025, 7:00 AM EDT - 1 year ago

Pulse Biosciences Announces FDA IDE Approval to Initiate its nsPFA Cardiac Surgery System Study for the Treatment of Atrial Fibrillation

Pulse Biosciences Proxy statement: Proxy Filing

Sep 3, 2025, 8:00 AM EDT - 1 year ago

Pulse Biosciences Proxy statement: Proxy Filing

Pulse Biosciences Announces First Successful Procedures in PRECISE Benign Thyroid Nodule (BTN) Study

Sep 2, 2025, 7:00 AM EDT - 1 year ago

Pulse Biosciences Announces First Successful Procedures in PRECISE Benign Thyroid Nodule (BTN) Study

Pulse Biosciences Announces Publication of First-In-Human Data for Treatment of Benign Thyroid Nodules in the Journal Thyroid

Aug 26, 2025, 7:00 AM EDT - 1 year ago

Pulse Biosciences Announces Publication of First-In-Human Data for Treatment of Benign Thyroid Nodules in the Journal Thyroid

Pulse Biosciences Proxy statement: Proxy Filing

Aug 18, 2025, 8:00 AM EDT - 1 year ago

Pulse Biosciences Proxy statement: Proxy Filing

Pulse Biosciences Transcript: Canaccord Genuity’s 45th Annual Growth Conference

Aug 13, 2025, 11:00 AM EDT - 1 year ago

Pulse Biosciences Transcript: Canaccord Genuity’s 45th Annual Growth Conference

Pulse Biosciences Earnings Call Transcript: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 1 year ago

Pulse Biosciences Earnings Call Transcript: Q2 2025

Pulse Biosciences Quarterly report: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 1 year ago

Pulse Biosciences Quarterly report: Q2 2025

Pulse Biosciences Earnings release: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 1 year ago

Pulse Biosciences Earnings release: Q2 2025

Pulse Biosciences Reports Business Updates and Second Quarter 2025 Financial Results

Aug 12, 2025, 4:05 PM EDT - 1 year ago

Pulse Biosciences Reports Business Updates and Second Quarter 2025 Financial Results

Pulse Biosciences To Present at the 45th Canaccord Genuity Annual Growth Conference

Aug 1, 2025, 7:00 AM EDT - 1 year ago

Pulse Biosciences To Present at the 45th Canaccord Genuity Annual Growth Conference

Pulse Biosciences Schedules Second Quarter 2025 Business Updates and Financial Results Conference Call for August 12, 2025

Jul 29, 2025, 4:05 PM EDT - 1 year ago

Pulse Biosciences Schedules Second Quarter 2025 Business Updates and Financial Results Conference Call for August 12, 2025

Pulse Biosciences Earnings Call Transcript: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Pulse Biosciences Earnings Call Transcript: Q1 2025

Pulse Biosciences Quarterly report: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Pulse Biosciences Quarterly report: Q1 2025

Pulse Biosciences Earnings release: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Pulse Biosciences Earnings release: Q1 2025

Pulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results

May 8, 2025, 4:05 PM EDT - 1 year ago

Pulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results

Pulse Biosciences To Present at the BofA Securities 2025 Health Care Conference

May 6, 2025, 4:05 PM EDT - 1 year ago

Pulse Biosciences To Present at the BofA Securities 2025 Health Care Conference

Pulse Biosciences' Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting

May 1, 2025, 7:00 AM EDT - 1 year ago

Pulse Biosciences' Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting

Pulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025

Apr 24, 2025, 4:05 PM EDT - 1 year ago

Pulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025

Pulse Biosciences' Nanosecond PFA Technology to be Featured at The Heart Rhythm Society 2025 Annual Meeting

Apr 23, 2025, 7:00 AM EDT - 1 year ago

Pulse Biosciences' Nanosecond PFA Technology to be Featured at The Heart Rhythm Society 2025 Annual Meeting

Pulse Biosciences Transcript: 24th Annual Needham Virtual Healthcare Conference

Apr 10, 2025, 9:30 AM EDT - 1 year ago

Pulse Biosciences Transcript: 24th Annual Needham Virtual Healthcare Conference

Pulse Biosciences Earnings Call Transcript: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

Pulse Biosciences Earnings Call Transcript: Q4 2024

Pulse Biosciences Annual report: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

Pulse Biosciences Annual report: Q4 2024

Pulse Biosciences Earnings release: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

Pulse Biosciences Earnings release: Q4 2024

Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2024 Financial Results

Mar 27, 2025, 4:05 PM EDT - 1 year ago

Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2024 Financial Results

LeisureSuitLarry
LeisureSuitLarry Aug. 18 at 1:37 PM
$PLSE 💪🏻
0 · Reply
TruthBroker2
TruthBroker2 Aug. 17 at 8:31 PM
$PLSE
0 · Reply
MaverikIT
MaverikIT Aug. 17 at 7:53 PM
@cynicaloptimist @Jblack500 @WAJeff let's $TWST and $PLSE ing again $NTRA $TXG ...
1 · Reply
TruthBroker2
TruthBroker2 Aug. 17 at 5:13 PM
$PLSE #1
0 · Reply
LeisureSuitLarry
LeisureSuitLarry Aug. 17 at 2:34 PM
$PLSE
0 · Reply
bob2013
bob2013 Aug. 17 at 11:58 AM
$PLSE Farapulse, please make room!! ( HE KNOWS)!!!
0 · Reply
nhjxie
nhjxie Aug. 17 at 9:32 AM
$PLSE elephants just started to jump into this small pond…
1 · Reply
TruthBroker2
TruthBroker2 Aug. 14 at 7:20 PM
$PLSE Long N Strong $SMMT
0 · Reply
ActionMack
ActionMack Aug. 14 at 4:59 PM
$PLSE dump and run
1 · Reply
letstalk8
letstalk8 Aug. 14 at 4:01 PM
$PLSE Time to cover your short and move on
2 · Reply
LeisureSuitLarry
LeisureSuitLarry Aug. 14 at 10:24 AM
$PLSE
0 · Reply
ActionMack
ActionMack Aug. 14 at 2:07 AM
$PLSE time to exit
0 · Reply
TruthBroker2
TruthBroker2 Aug. 13 at 3:57 PM
$ABBV $PLSE $SMMT $ISRG
0 · Reply
MaverikIT
MaverikIT Aug. 13 at 2:27 PM
@howardlindzon @Stocktwits getting good $PLSE $ 2K eyesballer$
0 · Reply
Rocketemojis007
Rocketemojis007 Aug. 12 at 11:42 PM
$PLSE wonder if pulse is watching Imricor as a possible takeover target. Be able to capture both CT and MRI markets?
0 · Reply
LeisureSuitLarry
LeisureSuitLarry Aug. 12 at 2:23 PM
$SMMT $PLSE
0 · Reply
TruthBroker2
TruthBroker2 Aug. 12 at 1:30 PM
$SMMT $PLSE Team Duggan .Genius!!!
0 · Reply
TruthBroker2
TruthBroker2 Aug. 11 at 9:08 PM
$PLSE Healthcareguru BoB Knows 🤣
0 · Reply
PatrickandFrankie
PatrickandFrankie Aug. 11 at 8:25 PM
$PLSE team Pulse! Yes I am
0 · Reply
arist442
arist442 Aug. 11 at 7:59 PM
$PLSE I'd like to learn more about nanopulse ablation in the treatment of breast cancer. Can anyone direct me to this information as it applies to PLSE and it's involement/trials in this area.
0 · Reply
TruthBroker2
TruthBroker2 Aug. 11 at 7:15 PM
$PLSE New All Time High Incoming
0 · Reply
BubbaHoTep
BubbaHoTep Aug. 11 at 6:59 PM
$PLSE presentation was Too Short. Could listen all day.
0 · Reply